Pharma To Market

What Pharma To Market does

Pharma To Market is a privately held regulatory affairs consulting company headquartered in Eight Mile Plains, Queensland, Australia, that helps pharmaceutical, biotechnology, and medical device companies register products and maintain compliance across the Asia-Pacific region. The company was founded in 2009 and operates through wholly-owned subsidiaries in five markets — Australia (Pharma To Market Pty Ltd), Singapore (Pharma To Market Pte Ltd), Malaysia (Pharma To Market Sdn Bhd), Thailand (Pharma To Market Co Ltd), and Vietnam (VPDD Pharma To Market, a representative office). Its service portfolio spans Regulatory and Market Access consulting, eSubmission Outsourcing, GMP Auditing and Compliance, Pharmacovigilance, and Training, supported by a proprietary eSubmission Software product for electronic regulatory dossier preparation in eCTD and NeeS formats. The company claims 200+ product registrations completed, 100+ active clients, and 14 health authority meetings facilitated across the region.

The firm's go-to-market is sales-led and direct, targeting enterprise pharmaceutical companies, mid-sized biopharmaceutical firms, and medical device/IVD manufacturers seeking APAC market entry or expansion. Named customers include UCB, Vifor Pharma, Otsuka Pharmaceuticals, Nissan Chemical, AFT Pharmaceuticals, Heraeus Medical, Radiometer, and Tianjin Pharmaceutical Da Ren Tang, indicating a buyer profile skewed toward multinational and regional enterprise accounts. Revenue is generated through project-based consulting engagements and retainer arrangements; pricing is quote-based and not publicly disclosed. Marketing channels include a regulatory news content library, industry events and workshops (including a co-organized workshop with the Pharmaceutical Society of Singapore in 2018), testimonials and case studies, and direct consultation requests. The firm maintains GDPR and Australian Privacy Act compliance posture and operates without any disclosed external institutional investment, suggesting a bootstrapped, founder-/management-owned capital structure.

Name

Pharma To Market

Legal name

Pharma To Market Pty Ltd

Website

https://pharmatomarket.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharma To Market is a privately held Australian-headquartered regulatory affairs consulting firm that helps pharmaceutical, biotechnology, and medical device companies register products and maintain compliance across the Asia-Pacific region, with wholly-owned entities in Australia, Singapore, Malaysia, Thailand, and Vietnam.

Ownership category

akta.pro rank

Headquarters

HQ city

Eight Mile Plains

HQ country

Australia

HQ region

Oceania

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Regulatory Consulting Services: Professional consulting services for regulatory affairs, market access, product registration, GMP compliance, and pharmacovigilance across Asia-Pacific markets. Revenue generated through project-based consulting engagements and retainer arrangements with pharmaceutical and medical device companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Pharma To Market is a regulatory affairs consulting company that helps pharmaceutical, biotechnology, and medical device companies register products and maintain compliance across Asia-Pacific markets. Its core offerings include eSubmission Software for electronic regulatory dossier preparation, supplemented by consulting services for regulatory strategy and market access, eSubmission outsourcing, GMP auditing and compliance, pharmacovigilance, and professional training. The company operates through local offices in Australia, Singapore, Malaysia, Vietnam, and Thailand to deliver these services across the APAC region.

Product overview

Pharma To Market is a regulatory affairs consulting company offering a portfolio of services focused on pharmaceutical regulatory submissions and market access across the Asia-Pacific region. The core offering includes eSubmission Software for electronic regulatory dossier preparation and submission, supported by consulting services such as Regulatory and Market Access Services, eSubmission Outsourcing, GMP Auditing & Compliance, Pharmacovigilance, and Training. These services help pharmaceutical companies register products and achieve compliance in markets including Australia, New Zealand, Singapore, Malaysia, Vietnam, Thailand, and other ASEAN countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory and Market Access Services

Quantifiable outcome

• 200+ product registrations achieved across Asia-Pacific markets
• +2 more outcomes

Named customers14 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Pharmaceutical Society of SingaporecoreStrategic or Co-development Partner · 26 October 2018Co-organized the Pharmaceutical Regulatory Affairs & Pharmacovigilance Asia Workshop held on 26th October 2018 in Singapore. This workshop brought together industry experts from MSD, Novartis, Roche, and Sanofi, along with Pharma To Market's Australian consultants, to provide regulatory and pharmacovigilance knowledge to pharmaceutical industry participants.

Scale indicators4 records

Recent moves4 records

Expansion highlights5 records

Emerging players

• ArisGlobal: Life sciences technology vendor offering regulatory information management and pharmacovigilance platforms. Competes with PTM on the technology-enabled portion of regulatory operations.
• Veeva Systems: Provider of Vault RIM and regulated content solutions for life sciences, competing most directly with PTM's eSubmission software. A platform-tech competitor that could subsume parts of PTM's submission workflow.
• LORENZ Life Sciences: Long-standing vendor of eCTD and regulatory submission software for health authorities and sponsors. Direct technology competitor to PTM's eSubmission product line.

Direct peers

• PharmaLex (Cencora): Global regulatory affairs and pharmacovigilance consultancy recently acquired by Cencora. Most direct comparable: operates the same regulatory + pharmacovigilance + GMP service model as PTM, but at significantly larger global scale.
• Arriello: Specialist regulatory affairs, pharmacovigilance and quality consulting firm for pharma and medical devices. Comparable mid-sized competitor with regional European focus but similar service mix to PTM.
• ProPharma Group: Pharma-focused regulatory, compliance and pharmacovigilance consulting firm serving biopharma and medical device sponsors. Closely mirrors PTM's consulting-led, multi-service regulatory model.

Broad incumbents

• IQVIA: Broad life sciences services platform with extensive APAC regulatory and pharmacovigilance capabilities. Competes for enterprise sponsors with bundled offerings; PTM is far smaller and more specialist.
• Parexel International: Large global CRO with dedicated regulatory and market access services covering APAC. Overlaps with PTM on regulatory submissions, eCTD and pharmacovigilance but bundles it within a much wider clinical/CRO portfolio.
• ICON plc: Global CRO with regulatory affairs, pharmacovigilance and clinical services across Asia-Pacific. Provides a larger-scale alternative for sponsors who might otherwise engage a specialist like PTM.

Others

• NNIT (Capgemini Engineering): Life sciences-focused IT and consulting arm of Capgemini serving pharma with regulatory, validation and pharmacovigilance services. Adjacent consulting/technology peer rather than a direct APAC regulatory competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharma-to-market

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma To Market